Superior Group Of Companies earnings release, August 4, 2026

Superior Group Of Companies, Inc. (SGC) · Form 8-K, Item 2.02 · Filed · SEC filing

SUPERIOR GROUP OF COMPANIES REPORTS SECOND QUARTER 2026 RESULTS

ST. PETERSBURG, Fla.,

August 4, 2026 – Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its second quarter 2026 results.

“We’ve demonstrated the earnings power of our diversified business with Branded Products performing especially well this quarter, resulting in an adjusted EPS that was more than double the prior year’s second quarter. We are navigating through soft market conditions, and we see growth opportunities ahead for all three of our attractive businesses,” said Michael Benstock, Chief Executive Officer. “Our guidance continues to reflect stronger results in the back half of the year given seasonal factors. Ultimately, our diverse end markets, high customer retention and flexible supply chain combined with our healthy balance sheet allows us to drive continued growth and optimize shareholder value including through our attractive dividend yield and opportunistic share repurchases.”

Second Quarter Results

For the second quarter ended

June 30, 2026, net sales were

$147.8 million, up from second quarter 2025 net sales of

$144.0 million. Net income was

$1.2 million or

$0.08 per diluted share compared to net income of

$1.6 million or

$0.10 per diluted share for the second quarter of 2025.

During the second quarter the Company recorded a trade name impairment charge in the Healthcare Apparel segment of $2.6 million (or $2.0 million net of tax, or $0.13 per diluted share). The charge does not affect the Company’s cash position, cash flow from operating activities or bank debt covenants.

On an adjusted basis, excluding the impairment charge, second quarter net income was $3.2 million or $0.21 per diluted share up from net income of $1.6 million, or $0.10 per diluted share for the second quarter of 2025. At the conclusion of this press release is a reconciliation of reported-to-adjusted results, including a description of the significant item.

Quarterly Dividend

The Board of Directors declared a quarterly dividend of $0.14 per share, payable August 28, 2026 to shareholders of record as of August 14, 2026.

2026 Full-Year Outlook

The Company continues to forecast full-year 2026 net sales in the range of $572.0 million to $585.0 million, up from 2025 net sales of $566.2 million, and full-year adjusted earnings per diluted share in the range of $0.54 to $0.66, up from $0.46 in 2025.¹

Webcast and Conference Call

The Company will host a webcast and conference call at 8:00am Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for international dialers. The Canadian toll-free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through August 18, 2026. To access the replay, dial 1-855-669-9658 in the United States or Canada, or 1-412-317-0088 from international locations. Please reference conference number 5851649 for replay access.

Financial statements

Income Statement

Three Months Ended June 30, — (In thousands, except shares and per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net sales147,836144,045288,714281,142
Costs and expenses:Cost of goods sold91,71788,719180,261175,375
Costs and expenses:Selling and administrative expenses51,32752,240101,695102,342
Costs and expenses:Interest expense, net9811,2501,8932,495
Costs and expenses:Tradename impairment charge2,6002,600
Costs and expenses:146,625142,209286,449280,212
Costs and expenses:Income before income tax (benefit) expense1,2111,8362,265930
Costs and expenses:Income tax (benefit) expense-10285210137
Costs and expenses:Net income1,2211,5512,055793
Net income per share:Basic0.080.10.140.05
Net income per share:Diluted0.080.10.140.05
Weighted average shares outstanding during the period:Basic14,495,14414,813,98414,562,08115,206,819
Weighted average shares outstanding during the period:Diluted14,907,81815,101,94214,912,83215,573,692
Weighted average shares outstanding during the period:Cash dividends per common share0.140.140.280.28

Income Statement

Three Months Ended June 30, — (In thousands, except shares and per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net income1,2211,5512,055793
Interest expense, net9811,2501,8932,495
Income tax (benefit) expense-10285210137
Segment depreciation and amortization2,8122,8885,5976,002
Corporate depreciation and amortization7290145180
Tradename impairment charge2,6002,600
Adjusted EBITDA(1)7,6766,06412,5009,607
Adjusted EBITDA margin(1)5.2%4.24.3%3.4
Net income1,2211,5512,055793
Add backs:Tradename impairment charge2,6002,600
Add backs:Tax impact of adjustments(2)-640-640
Add backs:Adjusted net income(3)3,1811,5514,015793
Add backs:Diluted net income per share0.080.10.140.05
Add backs:Add back items, after-tax, per diluted share0.130.13
Add backs:Diluted adjusted net income per share(3)0.210.10.270.05
Weighted average shares outstanding during the period:Diluted, as reported and adjusted14,907,81815,101,94214,912,83215,573,692

Income Statement

Three Months Ended June 30, — (In thousands, except shares and per share data)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Income before income tax expense1,2111,8362,265930
Interest expense, net9811,2501,8932,495
Corporate selling and administrative expenses5,4965,43711,22512,032
Segment depreciation and amortization2,8122,8885,5976,002
Tradename impairment charge2,6002,600
Total Segment Adjusted EBITDA(4)13,10011,41123,58021,459

Income Statement

Branded Products (in thousands)

For the Three Months Ended June 30, 2026: – Branded ProductsBranded ProductsFor the Three Months Ended June 30, 2026: – Healthcare ApparelHealthcare ApparelFor the Three Months Ended June 30, 2026: – Contact CentersContact CentersFor the Three Months Ended June 30, 2026: – Intersegment EliminationsIntersegment EliminationsFor the Three Months Ended June 30, 2026: – TotalTotal
Net sales98,39027,23123,094-879147,836
Cost of goods sold62,51818,26411,344-40991,717
Gross margin35,8728,96711,750-47056,119
Selling and administrative expenses26,0019,94610,354-47045,831
Tradename impairment charge2,6002,600
Add backs:Tradename impairment charge2,6002,600
Add backs:Segment depreciation and amortization1,3448196492,812
Add backs:Segment Adjusted EBITDA(4)11,215-1602,04513,100
Add backs:Less corporate selling and administrative expenses5,496
Add backs:Add back corporate depreciation and amortization72
Add backs:Adjusted EBITDA(1)7,676
For the Three Months Ended June 30, 2025:Net sales92,64728,25323,977-832144,045
For the Three Months Ended June 30, 2025:Cost of goods sold59,63118,23711,364-51388,719
For the Three Months Ended June 30, 2025:Gross margin33,01610,01612,613-31955,326
For the Three Months Ended June 30, 2025:Selling and administrative expenses25,43210,07811,612-31946,803
Add backs:Segment depreciation and amortization1,3958546392,888
Add backs:Segment Adjusted EBITDA(4)8,9797921,64011,411
Add backs:Less corporate selling and administrative expenses5,437
Add backs:Add back corporate depreciation and amortization90
Add backs:Adjusted EBITDA(1)6,064

Balance Sheet

December 31, — (In thousands, except shares and per share data)

June 30, – 2026 – (Unaudited)December 31, – 2025
Current assets:Cash and cash equivalents22,78723,691
Current assets:Accounts receivable, net93,948104,336
Current assets:Inventories90,49297,474
Current assets:Contract assets57,13448,903
Current assets:Prepaid expenses and other current assets15,10513,259
Current assets:Total current assets279,466287,663
Current assets:Property, plant and equipment, net35,29437,352
Current assets:Operating lease right-of-use assets11,55912,620
Current assets:Deferred tax asset14,97015,003
Current assets:Intangible assets, net42,89447,254
Current assets:Goodwill2,5832,583
Current assets:Other assets21,75419,369
Current assets:Total assets408,520421,844
Current liabilities:Accounts payable49,63148,343
Current liabilities:Other current liabilities49,72553,041
Current liabilities:Current portion of long-term debt7,5006,563
Current liabilities:Current portion of acquisition-related contingent liabilities612
Current liabilities:Total current liabilities107,468107,947
Current liabilities:Long-term debt74,46587,093
Current liabilities:Long-term pension liability15,23615,010
Current liabilities:Long-term acquisition-related contingent liabilities410826
Current liabilities:Long-term operating lease liabilities6,8807,939
Current liabilities:Other long-term liabilities10,67810,211
Current liabilities:Total liabilities215,137229,026
Shareholders’ equity:Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding 15,945,623 and 15,730,615 shares, respectively1616
Shareholders’ equity:Additional paid-in capital85,67384,628
Shareholders’ equity:Retained earnings110,206112,871
Shareholders’ equity:Accumulated other comprehensive loss, net of tax:-2,512-4,697
Shareholders’ equity:Total shareholders’ equity193,383192,818
Shareholders’ equity:Total liabilities and shareholders’ equity408,520421,844

Cash Flow

Six Months Ended June 30, — (In thousands, except shares and per share data)

Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
CASH FLOWS FROM OPERATING ACTIVITIESNet income2,055793
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization5,7426,182
Adjustments to reconcile net income to net cash provided by operating activities:Inventory write-downs4,6631,042
Adjustments to reconcile net income to net cash provided by operating activities:Credit loss expense1,6652,100
Adjustments to reconcile net income to net cash provided by operating activities:Share-based compensation expense1,6992,561
Adjustments to reconcile net income to net cash provided by operating activities:Tradename impairment charge2,600
Adjustments to reconcile net income to net cash provided by operating activities:Change in fair value of acquisition-related contingent liabilities196520
Adjustments to reconcile net income to net cash provided by operating activities:Non-cash operating lease expense2,1051,824
Adjustments to reconcile net income to net cash provided by operating activities:Other, net110182
Changes in assets and liabilities:Accounts receivable9,115-569
Changes in assets and liabilities:Contract assets-8,185-1,682
Changes in assets and liabilities:Inventories2,386-10,692
Changes in assets and liabilities:Prepaid expenses and other current assets-5681,267
Changes in assets and liabilities:Other assets-2,453-789
Changes in assets and liabilities:Accounts payable and other current liabilities-4,503-84
Changes in assets and liabilities:Other long-term liabilities1,108291
Full release

Disclosure Regarding Forward-Looking Statements

Certain matters discussed in this press release are

“ forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words

“ may,”

“ will,”

“ should,”

“ could,”

“ expect,” “ anticipate,”

“ estimate,”

“ believe,”

“ intend,”

“ project,”

“ potential,” or

“ plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release include 2026 guidance of net sales and earnings per diluted share and may also include, without limitation:

(1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash,

(2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; the impact of global conflicts, such as the Russia-Ukraine War and the joint U.S.-Israeli War with

Iran in 2026, uncertainties related to tariffs, duties, trade wars and related matters, supply disruptions, inflationary environments (including with respect to shipping costs and the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (

“

U.S.” or

“

United States”) in which the Company’ s customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel... (truncated)rnal control over financial reporting; and other factors described in the Company’ s filings with the Securities and Exchange Commission ("SEC"), including those risks described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 entitled "Risk Factors" and the Quarterly Report on Form 10-Q for the quarter ended

June 30, 2026. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

About Superior Group of Companies, Inc. (SGC):

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

Investor Relations Contact:

Investors@Superiorgroupofcompanies.com²

(In thousands, except shares and per share data)³⁴⁵

(1)

Adjusted EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense, impairments and depreciation and amortization expense. Adjusted EBITDA margin is defined as Adjusted EBITDA divided by net sales. The Company believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences, (iii) asset base (depreciation and amortization) and (iv) impairments. The Company uses Adjusted EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used Adjusted EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. Adjusted EBITDA is not a measure of financial performance under GAAP. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted EBITDA are significant components in understanding and assessing the Company’s results of operations. The Company’s Adjusted EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate Adjusted EBITDA in the same manner.⁶

(2)

The tax impact of adjustments includes the tax effect of each separate adjustment based on the statutory tax rate for the jurisdiction(s) in which the adjustment was taxable or deductible, and the tax effect of items that relate to tax specific financial transactions.

(3)

Adjusted net income and diluted adjusted net income per share, which are non-GAAP measures, are defined as net income (loss) and net income (loss) per share, excluding the impacts of impairment and pension plan termination charges. Management believes adjusted net income (loss) and diluted adjusted net income (loss) per share provides useful information to investors because it allows management, investors and others to evaluate and compare our operating results from period to period by removing the impact of impairment and pension plan termination charges that are not reflective of our core business. Adjusted net income and Diluted adjusted net income per share should not be considered in isolation or as an alternative to net income or net income per share or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted net income and Diluted adjusted net income per share are significant components in understanding and assessing the Company’s net income. The Company’s Adjusted net income and Diluted adjusted net income per share may not be comparable to a similarly titled measure of another company because other entities may not calculate Adjusted net income and Diluted adjusted net income per share in the same manner.

(4)

Segment Adjusted EBITDA, as reported below for each segment, is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, net, impairments and depreciation and amortization expense. Total Segment Adjusted EBITDA is a non-GAAP financial measure and is reconciled to its most closely comparable GAAP metric of income before income tax expense (benefit) in the table above.⁷⁸⁹

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Superior Group Of Companies earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.